| Adaptaquin |
Adaptaquin |
385786-48-1 |
| 4BP-TQS |
4BP-TQS |
360791-49-7 |
| N-(4-butylphenyl)-5-nitrofuran-2-carboxamide |
化合物C-170 |
346691-38-1 |
| NCGC00262650 |
NCGC00262650 |
344359-25-7 |
| JC-1 |
JC-1 |
3520-43-2 |
| U 18666A |
U 18666A |
3039-71-2 |
| 5H-Pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide, N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-6,7-dihydro-6-(methylamino)-, (6S)- |
5H-Pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide, N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-6,7-dihydro-6-(methylamino)-, (6S)- |
2238822-07-4 |
| Quinoline, 3-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]-7-methoxy- |
化合物BT173 |
2232180-74-2 |
| AS-1763 |
AS1763 |
2227211-00-7 |
| QCA570 |
QCA570 |
2207569-08-0 |
| YTX-465 |
YTX-465 |
2225824-53-1 |
| IIIM-290
(IIIM290) |
IIIM-290 |
2213468-64-3 |
| YKL-06-062 |
YKL-06-062 |
2172617-16-0 |
| N1-(2-(4-(4-chloro-2-fluorophenyl)piperazin-1-yl)phenyl)-N4,N4-dimethylbenzene-1,4-disulfonamide |
N1-(2-(4-(4-chloro-2-fluorophenyl)piperazin-1-yl)phenyl)-N4,N4-dimethylbenzene-1,4-disulfonamide |
2171065-77-1 |
| VTP50469 |
VTP50469 |
2169916-18-9 |
| Benzeneacetamide, α-[[6-(4-amino-1-piperidinyl)-3,5-dicyano-4-ethyl-2-pyridinyl]thio]- |
GSK 3685032 |
2170137-61-6 |
| BPK-29 |
BPK-29 |
2143467-62-1 |
| 2BAct(eIF2B activator 2BAct) |
2BAct(eIF2B activator 2BAct) |
2143542-28-1 |
| SHMT-IN-2 |
SHMT-IN-2 |
2102681-49-0 |
| Phosphinic acid, P,P-bis(1-aziridinyl)-, (1S)-1-[3-[3-[(dimethylamino)carbonyl]phenoxy]-4-nitrophenyl]ethyl ester |
Phosphinic acid, P,P-bis(1-aziridinyl)-, (1S)-1-[3-[3-[(dimethylamino)carbonyl]phenoxy]-4-nitrophenyl]ethyl ester |
2097713-69-2 |
QQ
微信
